3 Events Biotech Investors Need to Watch in 2013: Vical Incorporated (VICL) and More
It's make-or-break time in 2013. That's the situation for several biotech companies with critical phase 3 trials under way.
February 13th, 2013 - News
February 12th, 2013 - News
February 11th, 2013 - News
Returns since its inception in May 2014 (through February 19th, 2025)